Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Ali S. Taha

High Impact

Role not yet determined Is this you? Add your title

26 h-index 134 pubs 3,133 cited

  • Humans
  • Male
  • Female
  • Middle Aged
  • Anti-Inflammatory Agents, Non-Steroidal
  • Helicobacter pylori
  • Adult
  • Aged
  • Gastric Mucosa
  • Stomach Ulcer
  • Helicobacter Infections
  • Aspirin
  • Duodenal Ulcer
  • Gastritis
  • Peptic Ulcer

Biography and Research Information

OverviewAI-generated summary

Ali S. Taha's research has focused on the gastrointestinal effects of nonsteroidal anti-inflammatory drugs (NSAIDs) and the efficacy of various pharmacological agents in preventing and treating related ulcers and inflammation. He has investigated the role of famotidine in mitigating NSAID-induced gastroduodenal ulcers and esophagitis, as evidenced by multiple clinical trials. His work also includes studies on the correlation between chemical gastritis, Helicobacter pylori infection, and NSAID use in patients with peptic ulceration.

Beyond gastrointestinal research, Taha has contributed to studies in other medical areas, including a genetic investigation of Wilson's disease and research on the association between celiac disease and autoimmune thyroid disease. His scholarship metrics include an h-index of 26, with over 134 publications and more than 3,133 citations, reflecting a significant body of work. He is recognized as a highly cited researcher and has collaborated with Grover P. Miller at the University of Arkansas for Medical Sciences on shared publications.

Metrics

  • h-index: 26
  • Publications: 134
  • Citations: 3,133

Selected Publications

  • Drug-Drug Interaction Dataset Derived from FDA 2026 DailyMed Drug Labels (2026)
    Zenodo (CERN European Organization for Nuclear Research) DOI OpenAlex
  • Drug-Drug Interaction Dataset Derived from FDA 2026 DailyMed Drug Labels (2026)
    Zenodo (CERN European Organization for Nuclear Research) DOI OpenAlex
  • Drug-Drug Interaction Dataset Derived from FDA 2026 DailyMed Drug Labels (2026)
    Zenodo (CERN European Organization for Nuclear Research) DOI OpenAlex
  • The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications (2025)
    Neuroscience & Biobehavioral Reviews 8 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

1 Collaborator 1 Institution 1 Country

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics